Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 190
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 132
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies
Dawn Marie R. Davis, Aaron M. Drucker, Ali Alikhan, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 2, pp. e43-e56
Closed Access | Times Cited: 67
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
Antonio Torrelo, Barbara Rewerska, María Laura Galimberti, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 1, pp. 23-32
Open Access | Times Cited: 44
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
Svenja Müller, Laura Maintz, Thomas Bieber
Allergy (2024) Vol. 79, Iss. 6, pp. 1501-1515
Open Access | Times Cited: 44
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 18
The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
Aikaterini Tsiogka, Maria Kyriazopoulou, George Kontochristopoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4431-4431
Open Access | Times Cited: 52
Oral Janus kinase inhibitors for atopic dermatitis
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 35
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 32
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases
Jenne P. Ingrassia, Muhammad Haisum Maqsood, Joel M. Gelfand, et al.
JAMA Dermatology (2023) Vol. 160, Iss. 1, pp. 28-28
Closed Access | Times Cited: 30
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 27
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Aaron M. Drucker, Megan Lam, David Prieto‐Merino, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 9, pp. 936-936
Closed Access | Times Cited: 12
Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors
Patrick A. Ireland, Nicholas Jansson, Sascha Spencer, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 3, pp. 281-281
Closed Access | Times Cited: 10
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19
Thomas Bieber, Eugen Feist, Alan D. Irvine, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4910-4960
Open Access | Times Cited: 37
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
Thomas Bieber, Norito Katoh, Eric L. Simpson, et al.
Journal of Dermatological Treatment (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 31
Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis
C. Ertus, Lucie‐Marie Scailteux, Alain Lescoat, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 4, pp. 368-380
Closed Access | Times Cited: 18
Infection risk with JAK inhibitors in dermatoses: a meta‐analysis
Patrick A. Ireland, Matthew J Verheyden, Nicholas Jansson, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 7
Biologic and Small Molecule Therapy in Atopic Dermatitis
Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 6
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 11
Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis
Hyun Jin Yim, Tiffany Jean, Peck Y. Ong
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 5, pp. 289-301
Open Access | Times Cited: 3
Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis
Qianyu Chen, Lian Cui, Yifan Hu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22014-e22014
Open Access | Times Cited: 8
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials
Monika Marko, Rafał Pawliczak
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 1, pp. 121-134
Closed Access | Times Cited: 7
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome
Núria Garrós, Mireia Mallandrich, Negar Beirampour, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1895-1895
Open Access | Times Cited: 11
Itch in elderly patients: Origin, diagnostics, management
Martin Steinhoff, Sara Al‐Khawaga, Joerg Buddenkotte
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 1, pp. 42-49
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top